8-aminoquinoline has been researched along with tafenoquine in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (7.69) | 18.7374 |
1990's | 6 (46.15) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (30.77) | 24.3611 |
2020's | 2 (15.38) | 2.80 |
Authors | Studies |
---|---|
Bartlett, MS; Berman, JD; Dean, RA; Ellis, WY; Milhous, WK; Queener, SF; Smith, JW | 1 |
Baskin, SI; Fricke, RF; Scharf, BA | 1 |
Baskin, SI; Clark, JH; Kirby, SD; Steinhaus, RK | 1 |
Anders, JC; Chung, H; Theoharides, AD | 1 |
Bartlett, MS; Goheen, MP; Queener, SF; Shaw, MM; Smith, JW | 1 |
Eberhard, ML; Ellis, WL; Marley, SE; McGreevy, PB; Ruebush, TK; Steurer, FJ | 1 |
Brueckner, RP; Coster, T; Schuster, BG; Shmuklarsky, M; Wesche, DL | 1 |
Croft, SL; Gamarro, F; Yardley, V | 1 |
Baresel, PC; Campo, B; Magill, AJ; Ohrt, C; Rochford, R; Sampath, A; Tekwani, BL; Walker, LA | 1 |
Burrows, JN; Campo, B; Vandal, O; Wesche, DL | 1 |
Kaewpruk, N; Mungthin, M; Sitthichot, N; Suwandittakul, N; Tan-ariya, P; Ward, SA | 1 |
Calvaresi, EC; Genzen, JR | 1 |
Lampejo, T | 1 |
1 review(s) available for 8-aminoquinoline and tafenoquine
Article | Year |
---|---|
Killing the hypnozoite--drug discovery approaches to prevent relapse in Plasmodium vivax.
Topics: Aminoquinolines; Antimalarials; Chemical and Drug Induced Liver Injury; Disease Eradication; Drug Discovery; Humans; Liver; Malaria, Vivax; Plasmodium vivax; Recurrence; Sporozoites | 2015 |
1 trial(s) available for 8-aminoquinoline and tafenoquine
Article | Year |
---|---|
Prophylaxis of Plasmodium falciparum infection in a human challenge model with WR 238605, a new 8-aminoquinoline antimalarial.
Topics: Adult; Aminoquinolines; Animals; Antimalarials; Double-Blind Method; Female; Humans; Malaria, Falciparum; Male; Plasmodium falciparum | 1998 |
11 other study(ies) available for 8-aminoquinoline and tafenoquine
Article | Year |
---|---|
Efficacy of intermittent dosage of 8-aminoquinolines for therapy or prophylaxis of Pneumocystis pneumonia in rats.
Topics: Aminoquinolines; Animals; Clindamycin; Disease Models, Animal; Drug Administration Schedule; Female; Pneumonia, Pneumocystis; Primaquine; Rats; Rats, Inbred Strains; Specific Pathogen-Free Organisms; Trimethoprim, Sulfamethoxazole Drug Combination | 1992 |
Comparison of methemoglobin formers in protection against the toxic effects of cyanide.
Topics: Aminoquinolines; Aniline Compounds; Animals; Dose-Response Relationship, Drug; Hemoglobins; Ketones; Lethal Dose 50; Male; Methemoglobin; Mice; Mice, Inbred ICR; Motor Activity; Oxidation-Reduction; Primaquine; Propiophenones; Sodium Cyanide | 1992 |
Formation of methemoglobin and metmyoglobin using 8-aminoquinoline derivatives or sodium nitrite and subsequent reaction with cyanide.
Topics: Aminoquinolines; Chemical Phenomena; Chemistry, Physical; Cyanides; Humans; Indicators and Reagents; Kinetics; Methemoglobin; Metmyoglobin; Oxidation-Reduction; Primaquine; Protein Binding; Sodium Nitrite | 1990 |
Methemoglobin formation resulting from administration of candidate 8-aminoquinoline antiparasitic drugs in the dog.
Topics: Aminoquinolines; Animals; Antimalarials; Body Weight; Dogs; Hemoglobins; Male; Methemoglobinemia | 1988 |
Effects of 8-aminoquinolines on the ultrastructural morphology of Pneumocystis carinii.
Topics: Aminoquinolines; Humans; Microscopy, Electron; Pneumocystis; Primaquine | 1993 |
Evaluation of selected antiprotozoal drugs in the Babesia microti-hamster model.
Topics: Aminoquinolines; Animals; Antiprotozoal Agents; Babesiosis; Cricetinae; Drug Evaluation, Preclinical; Mesocricetus; Pyrroles; Quinazolines | 1997 |
Antileishmanial and antitrypanosomal activities of the 8-aminoquinoline tafenoquine.
Topics: Aminoquinolines; Animals; Antiprotozoal Agents; Female; Inhibitory Concentration 50; Leishmania donovani; Leishmaniasis; Macrophages; Mice; Mice, Inbred BALB C; Primaquine; Trypanosoma cruzi | 2010 |
Humanized mouse model of glucose 6-phosphate dehydrogenase deficiency for in vivo assessment of hemolytic toxicity.
Topics: Aminoquinolines; Anemia, Hemolytic; Animals; Antimalarials; Chloroquine; Combined Modality Therapy; Dapsone; Dose-Response Relationship, Drug; Doxycycline; Drug Evaluation, Preclinical; Erythrocyte Count; Erythrocyte Transfusion; Female; Glucosephosphate Dehydrogenase Deficiency; Humans; Mefloquine; Mice; Mice, Inbred NOD; Mice, SCID; Primaquine; Pyrimethamine; Reproducibility of Results; Sensitivity and Specificity; Transplantation, Heterologous | 2013 |
PFMDR1 POLYMORPHISMS INFLUENCE ON IN VITRO SENSITIVITY OF THAI PLASMODIUM FALCIPARUM ISOLATES TO PRIMAQUINE, SITAMAQUINE AND TAFENOQUINE.
Topics: Aminoquinolines; Antimalarials; Humans; Malaria, Falciparum; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Primaquine; Thailand | 2016 |
Evaluating Percentage-Based Reporting of Glucose-6-Phosphate Dehydrogenase (G6PD) Enzymatic Activity.
Topics: Adolescent; Adult; Aged; Aminoquinolines; Antimalarials; Child; Child, Preschool; Female; Glucosephosphate Dehydrogenase; Hematologic Tests; Humans; Infant; Malaria; Male; Middle Aged; Reference Values; Retrospective Studies; Young Adult | 2020 |
Is low-dose tafenoquine combined with dihydroartemisinin-piperaquine a potential risk factor for Plasmodium vivax resistance to 8-aminoquinolines?
Topics: Aminoquinolines; Artemisinins; Piperazines; Plasmodium vivax; Quinolines; Risk Factors | 2022 |